The effects of monoamine uptake inhibitors and methamphetamine on neostriatal 6-hydroxydopamine (6-OHDA) formation, short-term monoamine depletions and locomotor activity in the rat
- 1 May 1990
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 516 (1) , 1-7
- https://doi.org/10.1016/0006-8993(90)90889-j
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Variability among brain regions in the specificity of 6-hydroxydopamine (6-OHDA)-induced lesionsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
- IX. Neurochemical and functional consequences following 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) and methamphetamineLife Sciences, 1985
- Functional and pharmacological significance of brain dopamine and norepinephrine storage poolsBiochemical Pharmacology, 1980
- The effects of dopaminergic agents on the locomotor activity of rats after high doses of methylamphetaminePharmacology Biochemistry and Behavior, 1980
- A rapid method for the regional dissection of the rat brainPharmacology Biochemistry and Behavior, 1980
- Dopaminergic neuronal responses to a non-amphetamine CNS stimulantJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1979
- Species-Dependent Responsiveness to Nonamphetamine Central StimulantsPharmacology, 1979
- Studies on the capacity of mazindol and dita to act as uptake inhibitors or releasing agents for 3H-biogenic amines in rat brain tissue slicesEuropean Journal of Pharmacology, 1977
- Neuronal degeneration in rat brain induced by 6-hydroxydopamine; a histological and biochemical studyBrain Research, 1972
- Critical Values for Duncan's New Multiple Range TestBiometrics, 1960